Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 11, 2026, 4:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 148 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Ventricular Tachycardia (V-Tach) Clear all
Completed Not applicable Interventional Accepts healthy volunteers

Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

NCT03946072
View directory record Official record
Conditions
Neurocognitive Dysfunction
Interventions
Transseptal Aortic Approach Catheter Ablation Procedure, Retrograde Aortic Approach Catheter Ablation Procedure
Procedure
Lead sponsor
University of California, San Francisco
Other
Eligibility
18 Years and older
Enrollment
153 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2023
U.S. locations
20
States / cities
Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 14 more
Source: ClinicalTrials.gov public record
Updated Dec 26, 2023 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Phase 4 Interventional Results available

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

NCT01557842
View directory record Official record
Conditions
Ventricular Tachycardia, Ischemic
Interventions
Drug Treatment, Catheter Ablation
Drug · Device
Lead sponsor
Biosense Webster, Inc.
Industry
Eligibility
18 Years and older
Enrollment
15 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2014
U.S. locations
23
States / cities
Los Angeles, California • San Francisco, California • Aurora, Colorado + 14 more
Source: ClinicalTrials.gov public record
Updated Jun 8, 2017 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Not applicable Interventional Results available

Advanced Reperfusion Strategies for Refractory Cardiac Arrest

NCT03880565
View directory record Official record
Conditions
Cardiac Arrest, Extracorporeal Membrane Oxygenation Complication, Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Out-Of-Hospital Cardiac Arrest
Interventions
Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation, Standard Advanced Cardiac Life Support (ACLS) Resuscitation
Device
Lead sponsor
University of Minnesota
Other
Eligibility
18 Years to 75 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2020
U.S. locations
1
States / cities
Minneapolis, Minnesota
Source: ClinicalTrials.gov public record
Updated Mar 10, 2022 · Synced Oct 11, 2026, 4:02 PM EDT
Not yet recruiting Not applicable Interventional Accepts healthy volunteers

AI-guided Prediction and Treatment of Cardiac Arrest

NCT07452016
View directory record Official record
Conditions
Sudden Cardiac Arrest
Interventions
Machine learning-guided cardiac arrest prediction device
Device
Lead sponsor
MetroHealth Medical Center
Other
Eligibility
18 Years and older
Enrollment
68 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2029
U.S. locations
1
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Mar 16, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Phase 2 Interventional

Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT06005428
View directory record Official record
Conditions
CPVT1, Heart Defects, Congenital, Heart Diseases, Ventricular Tachycardia
Interventions
CRD-4730, Placebo
Drug
Lead sponsor
Cardurion Pharmaceuticals, Inc.
Industry
Eligibility
18 Years to 99 Years
Enrollment
7 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2025
U.S. locations
3
States / cities
Cincinnati, Ohio • Cleveland, Ohio • Houston, Texas
Source: ClinicalTrials.gov public record
Updated May 27, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Active, not recruiting Not applicable Interventional

Assessment of Combined CCM and ICD Device in HFrEF

NCT05855135
View directory record Official record
Conditions
Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
Interventions
OPTIMIZER® Integra CCM-D System (Treatment Arm)
Device
Lead sponsor
Impulse Dynamics
Industry
Eligibility
18 Years and older
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2027
U.S. locations
59
States / cities
Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 40 more
Source: ClinicalTrials.gov public record
Updated May 27, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Completed No phase listed Observational

The Signal-averaged ElectrocArdiogram in Long Term Follow-up of Chronic CHagas Disease - RIO de Janeiro Cohort

NCT01340963
View directory record Official record
Conditions
Chagas Cardiomyopathy, Cardiac Arrhythmia, Stroke, Left Ventricular Function Systolic Dysfunction, Cardiac Death
Interventions
Not listed
Lead sponsor
Universidade Gama Filho
Other
Eligibility
18 Years to 75 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1995 – 2012
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Dec 10, 2013 · Synced Oct 11, 2026, 4:02 PM EDT
Recruiting Not applicable Interventional

Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

NCT07650032
View directory record Official record
Conditions
Ventricular Tachycardia, Sustained, Ventricular Tachycardia, Monomorphic
Interventions
Ultra Low Temperature Ablation (ULTA)
Device
Lead sponsor
Adagio Medical
Industry
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
8
States / cities
Phoenix, Arizona • Long Beach, California • Boston, Massachusetts + 5 more
Source: ClinicalTrials.gov public record
Updated Aug 12, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Phase 2 Interventional

Treatment of an Inherited Ventricular Arrhythmia

NCT05122975
View directory record Official record
Conditions
Catecholaminergic Polymorphic Ventricular Tachycardia Type 1
Interventions
S48168 (ARM210), Matching Placebo
Drug
Lead sponsor
RyCarma Therapeutics, Inc.
Industry
Eligibility
18 Years to 65 Years
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2024
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Sep 19, 2024 · Synced Oct 11, 2026, 4:02 PM EDT
Enrolling by invitation Not applicable Interventional

Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)

NCT06964152
View directory record Official record
Conditions
Ventricular Tachycardia (VT), Premature Ventricular Contraction (PVC), Ventricular Fibrillation
Interventions
Computational electrocardiography and cardiac computed tomography mapping
Diagnostic Test
Lead sponsor
University of California, San Diego
Other
Eligibility
21 Years to 90 Years
Enrollment
250 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2034
U.S. locations
1
States / cities
La Jolla, California
Source: ClinicalTrials.gov public record
Updated May 9, 2025 · Synced Oct 11, 2026, 4:02 PM EDT
Completed Not applicable Interventional Results available

Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies

NCT01139814
View directory record Official record
Conditions
Atrial Flutter, Ventricular Tachycardia
Interventions
Amigo catheter robot
Device
Lead sponsor
Catheter Robotics, Inc.
Industry
Eligibility
18 Years and older
Enrollment
181 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2011
U.S. locations
11
States / cities
Newport Beach, California • Redwood City, California • Chicago, Illinois + 8 more
Source: ClinicalTrials.gov public record
Updated Apr 11, 2013 · Synced Oct 11, 2026, 4:02 PM EDT
Recruiting Phase 2 Interventional

A Phase 2 Study of CRD-4730 in CPVT

NCT06658899
View directory record Official record
Conditions
Catecholaminergic Polymorphic Ventricular Tachycardia
Interventions
CRD-4730, Placebo
Drug
Lead sponsor
Cardurion Pharmaceuticals, Inc.
Industry
Eligibility
18 Years to 99 Years
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2027
U.S. locations
5
States / cities
San Francisco, California • Morrisville, North Carolina • Houston, Texas + 2 more
Source: ClinicalTrials.gov public record
Updated Jul 9, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Not listed Phase 2 Interventional

Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

NCT02008461
View directory record Official record
Conditions
Supra-ventricular Tachyarrhythmias
Interventions
radiofrequency ablation, botulinum toxin injection
Procedure · Drug
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Network
Eligibility
18 Years to 70 Years
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2016
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated Sep 23, 2015 · Synced Oct 11, 2026, 4:02 PM EDT
Recruiting Not applicable Interventional

Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia

NCT06891456
View directory record Official record
Conditions
Ventricular Tachycardia, Ischemic Heart Disease, Sustained VT
Interventions
RFA Ablation, PFA Ablation
Device
Lead sponsor
Pasquale Santangeli
Other
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2028
U.S. locations
1
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Sep 3, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Completed Phase 4 Interventional Results available

Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia

NCT00851279
View directory record Official record
Conditions
Ventricular Tachycardia
Interventions
Magnetic irrigated ablation catheter
Device
Lead sponsor
Stereotaxis
Industry
Eligibility
18 Years to 80 Years
Enrollment
53 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2013
U.S. locations
2
States / cities
Indianapolis, Indiana • Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 24, 2015 · Synced Oct 11, 2026, 4:02 PM EDT
Completed Phase 4 Interventional Results available

The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock

NCT00787800
View directory record Official record
Conditions
Ventricular Tachycardia, Ventricular Fibrillation, Atrial Fibrillation, Supraventricular Tachycardia
Interventions
Dual Chamber ICD, Single Chamber ICD
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years to 90 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2011
U.S. locations
2
States / cities
Jacksonville, Florida • Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jul 24, 2014 · Synced Oct 11, 2026, 4:02 PM EDT
Completed No phase listed Observational

Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

NCT00284453
View directory record Official record
Conditions
Arrhythmias
Interventions
Peripheral blood sampling
Procedure
Lead sponsor
University of Pittsburgh
Other
Eligibility
18 Years and older
Enrollment
65 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2018
U.S. locations
2
States / cities
Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Feb 12, 2019 · Synced Oct 11, 2026, 4:02 PM EDT
Recruiting No phase listed Observational

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

NCT06575881
View directory record Official record
Conditions
Atrial Fibrillation, Ventricular Tachycardia, Premature Ventricular Contraction
Interventions
Not listed
Lead sponsor
Vanderbilt University Medical Center
Other
Eligibility
18 Years and older
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2029
U.S. locations
1
States / cities
Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated May 6, 2026 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Not applicable Interventional

Initial Management of Patients Receiving a Single Shock (IMPRESS)

NCT03531502
View directory record Official record
Conditions
Ventricular Tachycardia
Interventions
Ventricular Tachycardia Ablation, Standard Medical Therapy, Non-Invasive Programmed Stimulation (NIPS)
Procedure · Other
Lead sponsor
Saint Luke's Health System
Other
Eligibility
18 Years to 80 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2023
U.S. locations
1
States / cities
Kansas City, Missouri
Source: ClinicalTrials.gov public record
Updated Apr 13, 2023 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Not applicable Interventional Results available

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

NCT02481206
View directory record Official record
Conditions
Sudden Cardiac Death, Sudden Cardiac Arrest
Interventions
Wearable Cardioverter Defibrillator
Device
Lead sponsor
Zoll Medical Corporation
Industry
Eligibility
50 Years and older
Enrollment
66 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2017
U.S. locations
31
States / cities
Corona, California • Downey, California • Escondido, California + 28 more
Source: ClinicalTrials.gov public record
Updated Jan 19, 2021 · Synced Oct 11, 2026, 4:02 PM EDT
Completed Not applicable Interventional Results available

REASSURE AV Registry

NCT01074034
View directory record Official record
Conditions
Sudden Cardiac Death, Bradycardia
Interventions
AV Therapy Assessment-B301 investigational device
Device
Lead sponsor
Boston Scientific Corporation
Industry
Eligibility
18 Years and older
Enrollment
211 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2011
U.S. locations
36
States / cities
Anchorage, Alaska • Larkspur, California • Orlando, Florida + 32 more
Source: ClinicalTrials.gov public record
Updated Aug 1, 2017 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Early Phase 1 Interventional Results available

Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia

NCT02962076
View directory record Official record
Conditions
Ventricular Tachycardia
Interventions
[C-11] Meta-hydroxyephedrine radioactive tracer (MHED)
Drug
Lead sponsor
Khaled Awad, MD
Other
Eligibility
18 Years to 80 Years
Enrollment
11 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2024
U.S. locations
1
States / cities
St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Dec 24, 2024 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated Phase 3 Interventional Results available

Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation

NCT04208997
View directory record Official record
Conditions
Tachycardia, Ventricular, Catheter Ablation
Interventions
Antiarrhythmic drug
Drug
Lead sponsor
Vanderbilt University Medical Center
Other
Eligibility
18 Years and older
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2021
U.S. locations
1
States / cities
Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Nov 14, 2022 · Synced Oct 11, 2026, 4:02 PM EDT
Terminated No phase listed Observational

The Use of CT to Identify Damaged Heart Muscle in Patients Undergoing Ventricular Tachycardia Ablation.

NCT00583284
View directory record Official record
Conditions
Ventricular Tachycardia
Interventions
Not listed
Lead sponsor
The Cleveland Clinic
Other
Eligibility
21 Years and older
Enrollment
4 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2008
U.S. locations
1
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Jan 20, 2017 · Synced Oct 11, 2026, 4:02 PM EDT